Offer - Urjas Oil for just ₹ 1
Megaplat 100 Injection is a prescription drug, available for use as Injection. Colorectal Cancer are some of its major therapeutic uses. Other than this, Megaplat 100 Injection has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Megaplat 100 Injection is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Megaplat 100 Injection can also lead to other problems, which have been listed below. Such side effects of Megaplat 100 Injection normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Megaplat 100 Injection's effect during pregnancy is Severe and Severe while nursing. It is important to know if Megaplat 100 Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Megaplat 100 Injection related warnings section.
Megaplat 100 Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Megaplat 100 Injection in conditions like Arrhythmia. Some other conditions that can be affected by Megaplat 100 Injection are listed in the contraindications section below.
Drug interactions for Megaplat 100 Injection have been reported in the medical literature. See below for a complete list.
You should also be aware that Megaplat 100 Injection is not safe while driving, and is not addiction.
Megaplat 100 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Megaplat 100 Injection safe for pregnant women?
Megaplat has many dangerous side effects in pregnant women. If you are pregnant, do not consume Megaplat without medical advice.
Is the use of Megaplat 100 Injection safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Megaplat. It should only be taken after medical advice.
What is the effect of Megaplat 100 Injection on the Kidneys?
Megaplat may have mild side effects on the kidneys.
What is the effect of Megaplat 100 Injection on the Liver?
Megaplat can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Megaplat 100 Injection on the Heart?
The heart can be affected by Megaplat. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Megaplat 100 Injection unless your doctor advises you to do so -
Is this Megaplat 100 Injection habit forming or addictive?
Forming a habit of Megaplat 100 Injection has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Megaplat 100 Injection you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Megaplat 100 Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Megaplat 100 Injection cannot treat any kind of mental disorder.
Interaction between Food and Megaplat 100 Injection
You can take Megaplat 100 Injection with food.
Interaction between Alcohol and Megaplat 100 Injection
Taking alcohol with Megaplat 100 Injection can be dangerous.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 954-956
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 862
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Eloxatin (oxaliplatin)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Oxaliplan™ (oxaliplatin)
